Dendrimer News and Research

RSS
The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

New method shows how fatty acids are absorbed by single cells

New method shows how fatty acids are absorbed by single cells

Astodrimer sodium exhibits potent virucidal and antiviral activity against SARS-CoV-2 in vitro

Astodrimer sodium exhibits potent virucidal and antiviral activity against SARS-CoV-2 in vitro

The role of nanotechnology in the fight against COVID-19

The role of nanotechnology in the fight against COVID-19

New chemical trap catches trace glycoproteins, shows promise for targeted cancer treatments

New chemical trap catches trace glycoproteins, shows promise for targeted cancer treatments

Novel approach could help counter Influenza A virus in immune-compromised patients

Novel approach could help counter Influenza A virus in immune-compromised patients

New single-agent phototherapy system may form valuable new tool to combat cancer

New single-agent phototherapy system may form valuable new tool to combat cancer

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Dendrimer offers a simple way of creating vesicles

Dendrimer offers a simple way of creating vesicles

Starpharma receives approvals to commence phase 1 human clinical trial for DEP-Docetaxel

Starpharma receives approvals to commence phase 1 human clinical trial for DEP-Docetaxel

Research identifies new way for slow release drugs

Research identifies new way for slow release drugs

Nano-devices cross blood-brain barrier to deliver drug to treat cerebral palsy

Nano-devices cross blood-brain barrier to deliver drug to treat cerebral palsy

Milestone for Starpharma's drug delivery program

Milestone for Starpharma's drug delivery program

Starpharma receives FDA Special Protocol Assessment for bacterial vaginosis phase 3

Starpharma receives FDA Special Protocol Assessment for bacterial vaginosis phase 3

Dendrimers offers a new way to treat age-related macular degeneration, retinitis pigmentosa

Dendrimers offers a new way to treat age-related macular degeneration, retinitis pigmentosa

Potential nanoparticle treatment for macular degeneration and retinitis pigmentosa

Potential nanoparticle treatment for macular degeneration and retinitis pigmentosa

Dendrimers can capture circulating tumor cells in blood by biomimicry

Dendrimers can capture circulating tumor cells in blood by biomimicry

Partners of Bacterial Vaginosis sufferers at increased risk of HIV

Partners of Bacterial Vaginosis sufferers at increased risk of HIV